Fred Kerley Vows Clean Run at Enhanced Games, Sets Sights on 2028 Olympics Return

American sprinter Fred Kerley confirmed on 23 May 2026 that he will compete at the forthcoming Enhanced Games without performance-enhancing substances, while simultaneously maintaining his eligibility and ambition to race at the Los Angeles Olympics in 2028. The announcement places Kerley at the intersection of two competing visions for elite athletics — one anchored in traditional Olympic governance, the other in a privately funded circuit that has explicitly promised faster times through pharmacology.

The Enhanced Games, backed by Armenian-American billionaire and former browser-inventor Arascend Avedisian, was founded on a straightforward proposition: lift the doping bans, let athletes use sanctioned pharmaceutical assistance, and watch world records fall. The inaugural edition is scheduled to take place in Athens in 2025, with a second edition reportedly in development. For athletes willing to run inside that framework, the financial package is reported to be substantially larger than what standard track contracts offer — a consideration that has drawn both interest and scrutiny from within the sport.

Kerley's stated commitment to compete clean at the Enhanced Games — rather than under their permitted pharmaceutical protocol — is not a position every participating athlete has taken. Several high-profile names who joined the Enhanced Games roster did so on the understanding that they would compete under the event's permittable substance rules. Kerley's separate declaration, that he will abstain from those substances at the event while remaining eligible for Los Angeles 2028, introduces a complicating dynamic: a dual-commitment structure that the World Athletics regulatory framework was not designed to accommodate.

The question of dual eligibility is not trivial. World Athletics rules prohibit athletes who have served doping suspensions from competing at certain elite meets, though the specifics of how Enhanced Games participation — particularly for athletes not using banned substances at that event — would interact with Olympic qualification pathways remain under active legal review. Kerley, who served a suspension following a 2022 anti-doping tribunal finding, has a compliance record the sport's authorities will scrutinise closely as qualification for Los Angeles begins to take shape.

What makes the Kerley announcement structurally significant is the timing. He is not a declining veteran seeking a final pay day. He was the world's fastest 100-metre sprinter in 2021. He won Olympic silver in the 100 metres and gold in the 4x100 relay at Tokyo 2020. A return to competitive form at Los Angeles 2028 — if he achieves it — would place him among the most credentialed Olympians in American sprinting history. That such an athlete is choosing to split his competitive calendar between an Olympic qualification circuit and a privately funded alternative is a signal that the financial architecture of professional track and field may be undergoing a structural reorientation.

The sport's traditional revenue model — gate receipts, broadcast rights, national federation salaries, and sponsor endorsements mediated through Athletics Worldwide — has never fully closed the gap with professional team sports on a per-athlete basis. The Enhanced Games model, by contrast, offers a direct-to-athlete revenue share that bypasses federation structures entirely. Whether that model is sustainable, whether it produces competitive fields deep enough to generate genuine sporting interest, and whether it ultimately strengthens or fragments the Olympic movement are questions that Kerley's participation — even on his own clean terms — will help answer.

There is a counter-narrative worth surfacing. The Enhanced Games has faced consistent criticism from traditionalist voices inside the Olympic movement, including World Athletics president Sebastian Coe, who has described the event as a threat to athlete welfare and the integrity of sport. Coe argues that sanctioning pharmaceutical assistance — even under medical supervision — creates a ratchet effect that disadvantages athletes in nations and sports systems where access to such substances is unequal. That critique has structural force: a privately funded sprint meet where participants can legally use banned substances is, in material terms, only open to athletes who can afford to access those substances and the medical infrastructure to use them safely.

Kerley's own position — competing clean within that ecosystem — is not one the Enhanced Games was designed to accommodate. It is, in effect, a protest from within: a declaration that the financial and competitive opportunity offered by the event is sufficient to compete in it, but that the terms offered by the event are not acceptable to him personally. Whether other athletes follow that template or diverge toward the full pharmaceutical protocol will define the Enhanced Games' sporting character in ways that the current lineup, still taking shape, has not yet resolved.

The stakes for Los Angeles 2028 are concrete. The United States men's 100-metre sprint, absent a dominant figure since the retirement generation, remains genuinely open. Kerley at 34 years old would be competing against a new generation that has already posted times inside 9.9 seconds in the qualification window. The window itself, however, is long — qualification closes in mid-2028 — and Kerley's demonstrated ability to perform at major championships when healthy is not a credential the field can discount. Whether he reaches that starting line, and what governance questions he surfaces between now and then, will be a thread worth following across both circuits.

What remains uncertain is how the International Olympic Committee and World Athletics will ultimately treat athletes who have competed at Enhanced Games events, even without pharmaceutical assistance. The regulatory language in place as of May 2026 does not explicitly bar Enhanced Games participation for athletes who remain compliant with World Athletics anti-doping rules, but enforcement of that standard — and whether it holds through the qualification cycle — has not been tested at the level of a former world champion. That test is coming.